Quantum Genomics (ALQGC)

Quantum Genomics

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:ALQGC

1

Date	Time	Source	Headline	Symbol	Company
28/10/2022	06:00	GlobeNewswire Inc.	Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments	EU:ALQGC	Quantum Genomics
06/10/2022	16:00	GlobeNewswire Inc.	Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share	EU:ALQGC	Quantum Genomics
05/10/2022	16:00	GlobeNewswire Inc.	Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity	EU:ALQGC	Quantum Genomics
26/09/2022	14:06	GlobeNewswire Inc.	Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension	EU:ALQGC	Quantum Genomics
27/06/2022	16:47	GlobeNewswire Inc.	Quantum Genomics announces the appointment of its new Scientific Advisory Board	EU:ALQGC	Quantum Genomics
09/05/2022	16:00	GlobeNewswire Inc.	Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH	EU:ALQGC	Quantum Genomics
04/05/2022	16:00	GlobeNewswire Inc.	Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs	EU:ALQGC	Quantum Genomics
28/04/2022	16:00	GlobeNewswire Inc.	Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update	EU:ALQGC	Quantum Genomics
27/04/2022	12:20	GlobeNewswire Inc.	Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€	EU:ALQGC	Quantum Genomics
26/04/2022	15:35	GlobeNewswire Inc.	Quantum Genomics Raises a Gross Amount of Approximately € 15 M	EU:ALQGC	Quantum Genomics
31/03/2022	16:00	GlobeNewswire Inc.	Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606	EU:ALQGC	Quantum Genomics
28/03/2022	17:35	GlobeNewswire Inc.	Quantum Genomics Announces Granting of New Patents Protecting QGC606	EU:ALQGC	Quantum Genomics
14/03/2022	17:00	GlobeNewswire Inc.	Stéphane Cohen Joins Quantum Genomics as Director of Global Operations	EU:ALQGC	Quantum Genomics
06/12/2021	07:00	GlobeNewswire Inc.	Quantum Genomics Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar	EU:ALQGC	Quantum Genomics
25/11/2021	17:00	GlobeNewswire Inc.	Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.	EU:ALQGC	Quantum Genomics
07/10/2021	16:00	GlobeNewswire Inc.	Quantum Genomics and its Partners Reach a New Stage of Development in Asia	EU:ALQGC	Quantum Genomics
27/08/2021	08:45	GlobeNewswire Inc.	Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting	EU:ALQGC	Quantum Genomics
08/07/2021	06:00	GlobeNewswire Inc.	Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Difficult-to-Treat and Resista...	EU:ALQGC	Quantum Genomics
05/07/2021	06:00	GlobeNewswire Inc.	Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure at the Annual Congress of the European Societ...	EU:ALQGC	Quantum Genomics
19/05/2021	16:40	GlobeNewswire Inc.	Quantum Genomics Announces the Publication of New Scientific Article in Biomedicine & Pharmacotherapy Which Further Strengthe...	EU:ALQGC	Quantum Genomics
28/04/2021	16:03	GlobeNewswire Inc.	Quantum Genomics Secures €3 Million Non-dilutive Financing	EU:ALQGC	Quantum Genomics
21/04/2021	06:00	GlobeNewswire Inc.	Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart Failure Post Myocardial Infarctio...	EU:ALQGC	Quantum Genomics
20/04/2021	06:00	GlobeNewswire Inc.	Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in ...	EU:ALQGC	Quantum Genomics
25/03/2021	17:00	GlobeNewswire Inc.	Quantum Genomics Reports Full Year 2020 Operating and Financial Results	EU:ALQGC	Quantum Genomics
09/02/2021	17:00	GlobeNewswire Inc.	Orient EuroPharma Acquires Equity Stake in Quantum Genomics	EU:ALQGC	Quantum Genomics
09/10/2018	11:43	GlobeNewswire Inc.	Edison issues update on Quantum Genomics (ALQGC)	EU:ALQGC	Quantum Genomics
24/03/2016	12:00	GlobeNewswire Inc.	Quantum Genomics Raises €8.6 Million in U.S. and Europe	EU:ALQGC	Quantum Genomics
03/02/2016	19:21	GlobeNewswire Inc.	Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular Diseases	EU:ALQGC	Quantum Genomics